## Abstract Tumor growth requires a competent vascular supply and angiogenesis is now considered a potential target for cancer treatment. Chemotherapeutic drugs, and docetaxel in particular, chronically administered using a frequent schedule at low dose (metronomic dosing), can cause potent antiang
In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy
โ Scribed by Lilja Thoenes; Miriam Hoehn; Roman Kashirin; Manfred Ogris; Georg J. Arnold; Ernst Wagner; Michael Guenther
- Publisher
- Elsevier
- Year
- 2010
- Tongue
- English
- Weight
- 582 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1874-3919
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The use of peptide analogs in the therapy of prostate cancer is reviewed. The preferred primary treatment of advanced androgen-dependent prostate cancer is presently based on the use of depot preparations of LH-RH agonists. This treatment is likewise recommended in patients with rising PSA levels af
## Abstract Prostate cancer (PC) chemoprevention has generated considerable interest in the last decade and selenium and combinations of selenium have been recognized as one of the most efficacious chemopreventive agents against PC. This review focuses on a discussion of the knowledge hitherto gain
## Abstract Stimulation of tumor growth and induced hypercalcemia both may occur during the initiation of estrogen therapy in breast cancer. This study was conducted to determine whether cyclophosphamide (CTX) as an adjuvant to estrogen therapy might (1) prevent induced hypercalcemia or (2) achieve